Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (341-350 of 394) with videos related to

Pageof 40
Sort By:
Mayo Clinic Proceedings|February 13, 2025
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021Pojsakorn Danpanichkul, Kanokphong Suparan, Thanida Auttapracha, et al.
Human Molecular Genetics|June 27, 2023
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genesSamuel O Antwi, Michael Heckman, Launia White, et al.
World Journal of Gastroenterology|October 3, 2022
High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidenceEssa A Mohamed, Nasra H Giama, Abubaker O Abdalla, et al.
Hepatology (Baltimore, Md.)|September 1, 2018
Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical ValidationJohn B Kisiel, Brian A Dukek, Reddappa V S R Kanipakam, et al.
Gastro Hep Advances|June 9, 2025
Lower Frequency of <i>PNPLA3</i> Polymorphism in West African Populations and Divergent Associations With Hepatocellular CarcinomaPerapa Chotiprasidhi, Yvonne Ayerki Nartey, Karina Sato-Espinoza, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 20, 2015
Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantationRoongruedee Chaiteerakij, Xiaodan Zhang, Benyam D Addissie, et al.
Nature Communications|February 24, 2023
Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitisYounghun Han, Jinyoung Byun, Catherine Zhu, et al.
Cancers|March 13, 2024
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived XenograftsFaizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, et al.
The Journal of Biological Chemistry|June 7, 2013
Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regenerationIkuo Nakamura, Maite G Fernandez-Barrena, Maria C Ortiz-Ruiz, et al.
Gastroenterology|January 6, 2015
Unique genomic profile of fibrolamellar hepatocellular carcinomaHelena Cornella, Clara Alsinet, Sergi Sayols, et al.
Pageof 40

Showing results (341-350 of 394) with videos related to

Sort By:
Pageof 40
Mayo Clinic Proceedings|February 13, 2025
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021Pojsakorn Danpanichkul, Kanokphong Suparan, Thanida Auttapracha, et al.
Human Molecular Genetics|June 27, 2023
Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genesSamuel O Antwi, Michael Heckman, Launia White, et al.
World Journal of Gastroenterology|October 3, 2022
High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidenceEssa A Mohamed, Nasra H Giama, Abubaker O Abdalla, et al.
Hepatology (Baltimore, Md.)|September 1, 2018
Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical ValidationJohn B Kisiel, Brian A Dukek, Reddappa V S R Kanipakam, et al.
Gastro Hep Advances|June 9, 2025
Lower Frequency of <i>PNPLA3</i> Polymorphism in West African Populations and Divergent Associations With Hepatocellular CarcinomaPerapa Chotiprasidhi, Yvonne Ayerki Nartey, Karina Sato-Espinoza, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 20, 2015
Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantationRoongruedee Chaiteerakij, Xiaodan Zhang, Benyam D Addissie, et al.
Nature Communications|February 24, 2023
Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitisYounghun Han, Jinyoung Byun, Catherine Zhu, et al.
Cancers|March 13, 2024
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived XenograftsFaizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, et al.
The Journal of Biological Chemistry|June 7, 2013
Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regenerationIkuo Nakamura, Maite G Fernandez-Barrena, Maria C Ortiz-Ruiz, et al.
Gastroenterology|January 6, 2015
Unique genomic profile of fibrolamellar hepatocellular carcinomaHelena Cornella, Clara Alsinet, Sergi Sayols, et al.
Pageof 40